EGFR and lung cancer: To analyze the early response of EGFR ctDNA to EGFR-TKI treatments, we conducted a prospective study, wherein the quantitative changes in EGFR ctDNA were evaluated in the first 3 weeks of EGFR-TKI treatment for lung cancer with activating EGFR mutations.